Iradimed Co Stock Price on December 31, 2024
| IRMD Stock | USD 56.49 0.97 1.75% |
Below is the normalized historical share price chart for Iradimed Co extending back to July 16, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iradimed stands at 56.49, as last reported on the 6th of January, with the highest price reaching 57.00 and the lowest price hitting 55.70 during the day.
If you're considering investing in Iradimed Stock, it is important to understand the factors that can impact its price. Iradimed appears to be very steady, given 3 months investment horizon. Iradimed holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of risk over the last 3 months. We have found thirty technical indicators for Iradimed, which you can use to evaluate the volatility of the firm. Please utilize Iradimed's Risk Adjusted Performance of 0.0854, downside deviation of 1.86, and Market Risk Adjusted Performance of 0.2665 to validate if our risk estimates are consistent with your expectations.
The current year's Stock Based Compensation To Revenue is expected to grow to 0.04, whereas Total Stockholder Equity is forecasted to decline to about 46.1 M. . At present, Iradimed's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 103.59, whereas Price Earnings Ratio is forecasted to decline to 38.02. Iradimed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of July 2014 | 200 Day MA 47.079 | 50 Day MA 53.5101 | Beta 0.799 |
Iradimed |
Sharpe Ratio = 0.1192
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IRMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.06 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.25 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Iradimed is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iradimed by adding it to a well-diversified portfolio.
Price Book 8.4335 | Enterprise Value Ebitda 29.4401 | Price Sales 9.8678 | Shares Float 7.1 M | Dividend Share 0.45 |
Iradimed Main Headline on 31st of December 2024
Iradimed Corporation Short Interest Update by thelincolnianonline.com
Iradimed Corporation was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 105,000 shares, an increase of 22.0 percent from the November 30th total of 86,100 shares. Currently, 1.3 percent of the shares of the stock are sold short. Based on
Iradimed Valuation on December 31, 2024
It is possible to determine the worth of Iradimed on a given historical date. On December 31, 2024 Iradimed was worth 55.44 at the beginning of the trading date compared to the closed value of 55.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Iradimed stock. Still, in general, we apply an absolute valuation method to find Iradimed's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Iradimed where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Iradimed's related companies.
| Open | High | Low | Close | Volume | |
| 54.54 | 55.37 | 53.37 | 55.09 | 28,235 | |
12/31/2024 | 55.44 | 55.44 | 54.60 | 55.00 | 21,902 |
| 55.15 | 55.38 | 54.22 | 54.94 | 28,512 |
| Backtest Iradimed | | | Iradimed History | | | Iradimed Valuation | Previous | Next |
Iradimed Trading Date Momentum on December 31, 2024
| On January 02 2025 Iradimed Co was traded for 54.94 at the closing time. The top price for the day was 55.38 and the lowest listed price was 54.22 . The trading volume for the day was 28.5 K. The trading history from January 2, 2025 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.11% . The trading delta at closing time against the current closing price is 2.00% . |
Iradimed Fundamentals Correlations and Trends
By evaluating Iradimed's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Iradimed's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Iradimed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Iradimed Stock history
Iradimed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iradimed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iradimed will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iradimed stock prices may prove useful in developing a viable investing in Iradimed
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.6 M | 13 M | |
| Net Income Applicable To Common Shares | 14.8 M | 15.5 M |
Iradimed Quarterly Net Working Capital |
|
Iradimed Stock Technical Analysis
Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Iradimed Period Price Range
Low | January 6, 2025
| High |
0.00 | 0.00 |
Iradimed Co cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Iradimed January 6, 2025 Market Strength
Market strength indicators help investors to evaluate how Iradimed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iradimed shares will generate the highest return on investment. By undertsting and applying Iradimed stock market strength indicators, traders can identify Iradimed Co entry and exit signals to maximize returns
Iradimed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iradimed's price direction in advance. Along with the technical and fundamental analysis of Iradimed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iradimed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0854 | |||
| Jensen Alpha | 0.178 | |||
| Total Risk Alpha | 0.1564 | |||
| Sortino Ratio | 0.0937 | |||
| Treynor Ratio | 0.2565 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Iradimed Stock analysis
When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |